Advanced Filters
noise
Found 1,889 clinical trials
E Erin Wetherbee, MD

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Patients with stage I non-small cell lung cancer have been historically treated with surgery whenever they are fit for an operation. However, an alternative treatment known as stereotactic radiotherapy now appears to offer an equally effective alternative. Doctors believe both are good treatments and are therefore conducting this study to …

18 years of age All Phase N/A
S Sebastien Couraud, Prof

Mobile Lung Cancer Screening

Lung cancer screening using low-dose CT (LDCT) has been shown to reduce mortality in high-risk populations. In 2022, the French National Cancer Institute (INCa) issued guidelines recommending screening for individuals aged 50-74 with a history of heavy smoking, including current smokers or those who quit less than 15 years ago. …

50 - 75 years of age All Phase N/A
S Soraya Fenniche, MD

Tunisian Lung Cancer Study

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.

18 years of age All Phase N/A
A Ashley Dang-Chu

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

This collaborative screening protocol, developed by the Lung Cancer Mutation Consortium (LCMC) and supported by the Thoracic Surgery Oncology Group (TSOG), is designed to determine the feasibility of comprehensive molecular profiling to detect actionable oncogenic drivers in patients with suspected early stage lung cancers scheduled to undergo biopsies to establish …

years of age All Phase N/A
R Rita Mehta, MD

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened …

18 - 80 years of age All Phase N/A

Lung cAncer Robotic Comparative Study

To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.

18 years of age All Phase N/A
J James J. Tsay, MD, MSc

Lung Cancer Biomarkers and Screening

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

50 years of age All Phase N/A
Y Yongchang Zhang, MD

Survival Outcomes of Lung Cancer

This is a prospective study to analyze the survival outcomes of different groups about lung cancer patients.

18 years of age All Phase N/A
S Sarah Neufeld

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

Determine whether CT-based multiparametric analytical models may improve prediction of biopsy and treatment outcome in patients undergoing screening CT scan and/or treatment for early stage lung cancer

18 - 99 years of age All Phase N/A

Rural Illinois Lung Cancer Screening Initiative

The role of this observational study is to access the feasibility of providing lung cancer screening using a designated nurse navigator through lung cancer screening clinic. Eligible participants will be identified using medical records, eligibility will be confirmed through phone call, screening visits will be scheduled as in-person visit or …

50 - 80 years of age All Phase N/A

Simplify language using AI